Back to Dashboard
ADPT · Healthcare

Adaptive Biotechnologies Corp

USA Healthcare Filing: 2026-06-30
38/100
Smart-money confidence
Below average interest

No standout activity across the feeds we track.

Stocks scoring 25–45 beat the S&P 500 45.3% of the time over the next three months, since 2015. How we measured this →

10
hedge funds
hold it · 2 added, 6 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$4.5B
Industry
Diagnostics & Research
Sector
Healthcare
Exchange
NasdaqGS
About ADAPTIVE BIOTECHNOLOGIES CORP

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers…

Who's behind the signal
Every informed buyer we can see on ADPT, across all three feeds.
Hedge funds · 10
D.E. Shaw & Co Increased +135%
Renaissance Technologies Increased +26%
+4 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
Company insiders Selling
Recent sells69
Not a model pick — but on our radar. ADAPTIVE BIOTECHNOLOGIES CORP isn't in the top-10 model right now, but 10 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
10
Investors
0
New positions
2
Increasing
6
Decreasing
2
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to ADAPTIVE BIOTECHNOLOGIES CORP
Insider Trading (Form 4)
Recent trades by company officers and directors — filed within 2 days of each trade
Bearish
Sentiment
0
Buys
69
Sells
Date Insider Title Action Shares Price Value
2026-11-13 RUBINSTEIN JULIE Insider SELL 11,466 $28.93 $331,711
2026-11-12 RUBINSTEIN JULIE Insider SELL 11,881 $29.40 $349,301
2026-11-11 BOBULSKY SUSAN Insider SELL 1,875 $32.00 $60,000
2026-11-11 RUBINSTEIN JULIE Insider SELL 6,898 $31.22 $215,356
2026-11-11 RUBINSTEIN JULIE Insider SELL 4,983 $30.29 $150,935
2026-11-10 RUBINSTEIN JULIE Insider SELL 1,900 $30.41 $57,779
2026-11-10 RUBINSTEIN JULIE Insider SELL 9,981 $29.35 $292,942
2026-11-09 RUBINSTEIN JULIE Insider SELL 2,400 $30.58 $73,392
2026-11-09 RUBINSTEIN JULIE Insider SELL 8,381 $30.15 $252,687
2026-11-09 RUBINSTEIN JULIE Insider SELL 1,100 $28.87 $31,757
2026-11-06 RUBINSTEIN JULIE Insider SELL 3,481 $27.88 $97,050
2026-11-06 RUBINSTEIN JULIE Insider SELL 8,400 $27.32 $229,488
2026-11-05 RUBINSTEIN JULIE Insider SELL 500 $27.70 $13,850
2026-11-05 RUBINSTEIN JULIE Insider SELL 5,455 $26.88 $146,630
2026-11-05 RUBINSTEIN JULIE Insider SELL 5,926 $26.10 $154,669
2026-11-04 RUBINSTEIN JULIE Insider SELL 7,881 $26.60 $209,635
2026-11-04 RUBINSTEIN JULIE Insider SELL 4,000 $25.78 $103,120
2026-11-03 RUBINSTEIN JULIE Insider SELL 11,881 $25.98 $308,668
2026-11-02 RUBINSTEIN JULIE Insider SELL 2,585 $26.34 $68,089
2026-11-02 RUBINSTEIN JULIE Insider SELL 9,296 $25.23 $234,538
Showing the 20 most recent of 69 buys & sells.
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ADAPTIVE BIOTECHNOLOGIES CORP or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime · Privacy